Strattera (atomoxetine) Treatment Report
Generic Name: Atomoxetine
What is Strattera?
Strattera® is a brand name for the drug atomoxetine HCL, a selective norepinephrine reuptake inhibitor used in the treatment of attention deficit hyperactivity disorder (ADHD).
Reasons taken & Efficacy
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Depression | 1 | 0 |
Mouse over the table for more information
Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Course of treatment ended
|
1 | 100% |
|
|
Not indicated
|
1 | 100% |
|
Stopped Taking Strattera
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
Adherence, Burden & Cost See details from patient evaluations ▼
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.